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Highlights 
Epilepsy surgery carries well defined surgical and neurological risks, which need to be balanced against 
the risks of morbidity and mortality from continued seizures, and the chances of seizure remission with 
surgery. 
The frequency of unexpected persistent neurological adverse events, which can affect quality of life, was 
2.2% following epilepsy surgery. 
Subdural EEG recordings were associated with increased risk of serious site-specific infection  
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Abstract 
Introduction 
Epilepsy surgery is an effective treatment for refractory focal epilepsy. Risks of surgery need to be considered 
when advising individuals of treatment options. We describe the frequency and nature of physical adverse 
events associated with epilepsy surgery in a single center. 
Material and Methods 
We reviewed the prospectively maintained records of adults who underwent epilepsy surgery at our center 
between 1990 and 2014 to identify peri/postsurgical adverse events. These were categorized into 
neurological deficits and those related to surgery (e.g. wound infections).  Neurological deficits were 
categorized as expected or unexpected and into transient (≤3 months) or persistent (>3 months),  
Results 
There were 911 procedures with no peri-operative deaths. Persistent neurological adverse events were seen 
following 157 (17.2%) procedures.  The most common persistent expected complication was quadrantanopia 
after temporal lobe resections (72/764, 9.4%). Unexpected persistent neurological complications occurred in 
20 procedures (2.2%) and included: quadrantanopia (6, 0.7%); hemianopia (2, 0.2%); hemi/mono-
paresis/sensory loss (9, 1%); dysphasia (10, 1%); frontalis muscle weakness (2, 0.2%); and oculomotor 
weakness (1, 0.1%).    
106 surgery related adverse events occurred in 83 procedures, with severe infections requiring bone-flap 
removal in 24 (2.6%) procedures and intracranial infections in 8 (0.9%). The risk of post-resective severe 
infection increased by 4 fold (OR 4.32, 95% CI 2.1 to 8.9, p<0.001) with use of subdural EEG monitoring prior 
to resection. In consequence, in August 2011 we introduced antibiotic coverage in all individuals undergoing 
intracranial monitoring. Also, after August 2011 there was greater use of Stereo-EEG (SEEG) than subdural 
(OR 9.0 CI 0.36 to 224.2, p=0.18 ns). One complicated by severe infection. Other surgical complications 
included haematoma (0.3%), hydrocephalus (0.3%) and CSF leak (1.2%).  None had permanent 
complications.  
Conclusions  
Adverse event rates are similar to other series. Epilepsy surgery carries well defined surgical and 
neurological risks. The risks of somatic adverse events, in addition to neuropsychiatric and 
neuropsychological complications need to be made clear to individuals considering this treatment option.  
Keywords: epilepsy surgery, adverse events, neurological deficits 
 
This research did not receive any specific grant from funding agencies in the public, commercial, or 
not-for-profit sectors, and was supported by NIHR UCLH-UCL Biomedical Research Centre.    
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1. Introduction 
Surgical removal of the epileptic focus is effective for some individuals with refractory focal epilepsy, with up 
to 80% of those operated having seizure remissions of at least one year (Jutila et al., 2002; de Tisi et al., 
2011). As in any surgical procedure, detailed knowledge of risks is a prerequisite to enable adequate pre-
surgical advice to individuals. The perception of risk may be one of the major factors influencing an 
individual’s decision to undergo surgery.  
Many observational studies on epilepsy surgery outcome include adverse event data. Despite this, there are 
few large series specifically addressing complications. We recently published the long-term seizure outcome 
of epilepsy surgery at our centre (de Tisi et al., 2011) and the neuropsychological (Baxendale et al., 2012) and 
psychiatric complications (Cleary et al., 2012). Here we describe the frequency and nature of physical adverse 
events associated with epilepsy surgery in the same cohort over a 25 year period. 
 
 
2. Material and Methods 
We retrospectively reviewed the prospectively maintained records of adults who underwent epilepsy surgery 
at the National Hospital for Neurology and Neurosurgery (NHNN), between 15 February 1990, and 31 
December 2014, for peri/post-surgical complications. One or more adverse events may be recorded after a 
single procedure.     
Post-operative follow-up included: neurosurgical review at 2-3 months after surgery, neurological review at 3 
and 12 months post-op, brain imaging (MRI) at 3 months after surgery and neuropsychology assessments at 
3 and 12 months after surgery.  
Adverse events were categorized into neurological (neurological deficits following surgery) and surgical 
(general adverse events related to surgery) (Figure 1). Neurological adverse events were categorized into 
transient (lasting ≤3 months) or persistent (lasting >3 months) and were further grouped into those that 
were expected or unexpected.  
Neurological adverse events included: quadrantanopia, hemianopia, hemiparesis/sensory loss, monoparesis/ 
sensory loss, dysphasia, oculomotor weakness and frontalis muscle weakness.  
Quadrantanopia was determined by perimetry and was recorded if it was severe enough to prevent driving in 
the UK.  In the majority of subjects visual fields were assessed using the binocular Estermann test while in a 
minority Goldmann perimetry was used. For the Estermann test the following is regarded as unacceptable for 
driving in the UK: a central loss of a cluster of 4 or more adjoining points that is either wholly or partly within 
the central 20° area, a loss consisting of both a single cluster of 3 adjoining missed points up to and including 
20° from fixation, and any additional separate missed points within the central 20° area and any central loss 
that is an extension of hemianopia or quadrantanopia of size greater than 3 missed points. Goldmann 
perimetry requires a field of at least 120° on the horizontal measured using a target equivalent to the white 
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Goldmann III4e setting and extension should be at least 50° left and right, to drive in the UK. There should be 
no significant defect in the binocular field that encroaches within 20° of the fixation above or below the 
horizontal meridian.  
An expected neurological complication was defined as an anticipated sequel of a surgical procedure based on 
the proximity of resection to eloquent structures, for example, upper quadrantanopia following anterior 
temporal lobe resection, hemi/monoparesis after surgery involving the motor strip or worsened weakness 
following hemispherectomy. An unexpected adverse event was any neurological deficit following surgery that 
was not predicted to occur.   
Surgery-related adverse events included: infection needing antibiotics, venous thrombosis (DVT)/ pulmonary 
embolism (PE), hydrocephalus, headache persisting over 3 months and affecting quality of life, and CSF 
leakage needing re-suturing. Infection needing antibiotics was further categorized into infection involving the 
surgical site or elsewhere. Surgical site infection included intracerebral and epidural abscesses, meningitis 
and bone flap infection necessitating removal with subsequent cranioplasty. Severe infection was defined as 
intracranial infection and/or bone-flap infection requiring removal.  
All surgical procedures were included in the report of the total adverse event rates, demographic data, 
complication rates according to type of surgery, and temporal analysis of adverse events. The chi-square test 
was used to examine the relationship between categorical variables. A series of binary logistic regression 
models were used to examine likelihood of having adverse events (neurological and surgical), persistent 
neurological adverse events and unexpected persistent neurological adverse events between temporal and 
extra-temporal surgical procedures. We also performed a logistic regression model to determine the 
influence of age on persistent neurological complications. Odds ratios with corresponding 95% confidence 
intervals were calculated. P values less than 0.05 were considered significant. SPSS version 21 was used for 
all statistical analyses. 
All individuals consented to the surgical procedures. This exercise was approved by our local Research Ethics 
Committee as a service evaluation that did not require individual patient consent. 
 
3. Results 
3.1 Descriptive statistics  
A total of 911 procedures were performed on 887 individuals (481[55%] female). Twenty four had repeat 
surgical procedures.  Age at surgery ranged from 16-68 years with a mean age of 34.5 SD±10.2 years. There 
were no surgery related deaths. The post-operative follow up period ranged between 1 year and 24 years 
with a median of 9 years. 
Of the 911 procedures 764 (84%) were temporal; 91 (10%) frontal; 21 (2.3%) parietal; 10 (1.1%) occipital 
lobe resections; with 16 (1.8%) hemispherectomies; 4 (0.4%) multiple subpial transections and 5 (0.5%) 
corpus-callosotomies (Table 1).   
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Following 911 procedures, at least one adverse event was reported in 240 (26.3%) procedures, with a total of 
157 (17.2%) neurological only (persistent/transient) and 63 (6.9%) surgical only, and 20 (2.2%) having both 
types. A higher percentage of extra-temporal procedures (38.8%) than temporal lobe procedures (24%) were 
complicated by adverse events (Table 1).  
Out of 118 lesionectomies (temporal and extra-temporal) performed, 27 (22.9%) procedures had at least one 
adverse event with 16 (13.6%) procedures having only neurological adverse events (persistent/transient), 9 
(7.6%) having only surgical adverse events, and 2 (1.7%) having both neurological and surgical adverse 
events (Table 1).  
 
 
3.2 Neurological adverse events 
Neurological adverse events were reported after 177 of the 911 procedures (19.4%) with 20 (2.2%) being 
unexpected persistent and 17 (1.9%) unexpected transient (Figure 2). Of the 764 temporal lobe resections, 
135 (17.7%) had neurological adverse events with 19 (2.5%) being unexpected persistent and 9 (1.2%) 
unexpected transient, while 42 (28.6%) extra-temporal procedures had neurological adverse events with 1 
(0.7%) having unexpected persistent and 8 (5.4%) unexpected transient neurological adverse events. 
Of the total 911 procedures, persistent quadrantanopia (77, 8.5%) was the most common persistent expected 
adverse event and dysphasia (10, 1.1%) was the most common unexpected adverse event. Transient 
dysphasias (17, 1.9%) and hemiparesis/sensory-loss (7, 0.8%) were the most frequent transient expected 
and transient unexpected adverse events (Table 2). Seventy two of the 77 expected persistent 
quadrantanopias followed temporal lobe resections.       
Quadrantanopia was the most common expected persistent adverse event after temporal lobe procedures 
(72, 9.4%) while dysphasia (10, 1.3%) was the most frequent unexpected persistent neurological adverse 
event. Persistent visual field defects including quadrantanopia and hemianopia were common expected 
adverse events after extratemporal procedures (9.5%), followed by hemi/monoparesis (6.8%)(Table 2). 
Logistic regression analysis showed no association between persistent neurological adverse events and age at 
operation (OR-1.01; 95% CI 0.97, 1.05; p=0.54). Logistic regression models predicted higher odds of having 
adverse events (combined neurological and surgical) (OR 2.01; 95% CI 1.39, 2.91; p<0.001) and neurological 
adverse events (OR 1.86; 95% CI 1.25, 2.79; p<0.001) following extra-temporal procedures compared to 
temporal procedures.  After adjustment for gender of the patient and age at surgery, there were higher odds 
of having adverse events (combined neurological and surgical) (OR 2.14; 95% CI 1.48, 3.10; p<0.001) in extra 
temporal procedures compared to temporal procedures 
 
3.3 Surgical adverse events 
There were 106 surgical adverse events following 83 of the 911 procedures. Superficial infections at the 
surgical site (35, 3.8%) were the most common adverse events, followed by infections requiring bone flap 
removal (24, 2.6%); persistent headache (16, 1.8%) and intracranial infections including meningitis (8, 
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0.9%)(Table 3). 7.6% (58/764) of temporal lobe procedures had surgical adverse events (78 total adverse 
events) compared with 17% (25/147) of extratemporal procedures (28 total adverse events) (χ2= 13.2, 
p=0.0003).  
Severe infections, defined as intracranial infection and those requiring bone flap removal were more common 
8.9% (15/168) in those who had undergone intracranial EEG monitoring. Severe infection with subdural 
electrodes (with or without depth electrodes) was 9.6% (14/148) prior to surgery compared with 2.4% 
(18/763) in those who had not undergone subdural monitoring. This amounted to a 4 fold increase in risk 
with subdural recordings (OR 4.32, 95% CI 2.1 to 8.9, p<0.001).  
The total infection rate for temporal lobe procedures was 6.5% (50/764) while it was 15% (22/147) with 
extra temporal procedures (χ2=12.01, p=0.0005). This higher infection rate was the main contributor 
towards adverse events in extra-temporal procedures.  Extra temporal procedures were 6.7 times more likely 
(CI 4.5, 9.8, p<0.0001) to have intracranial monitoring (49%, 72/147) than temporal procedures (12.5%, 
96/764), which explains the higher infection rates and total adverse event rates with extra-temporal 
procedures.     
The infection rates associated with subdural EEG monitoring led to a revision of practice in August 2011 
including the introduction of prophylactic antibiotic administration (typically Teicoplanin) for the duration of 
the intracranial monitoring. We did not use prophylactic antibiotics prior to August 2011. The rate of severe 
infections with subdural grids prior to August 2011 was 9.2% (11/120). Since after that time, the severe 
infection rate with subdural grids was not significantly different at 10.7% (3/28). The median duration of 
subdural grid recordings was the same at 8 days, in both those with, and without, severe infections (p=0.53).  
Moreover, there was widespread usage of SEEG rather than subdural grids after August 2011. “SEEG only” 
approach was utilized in only 2/122 (1.6%) procedures prior to August 2011. After August 2011, 18/46 
(39%) underwent SEEG only monitoring prior to surgery and only 1 (2%, 1/46) was complicated by severe 
infections (OR 9.0 CI 0.36 to 224.2, p=0.18 ns). 
Other adverse events which were not classified under the above categories included: dental damage 1 (0.1%), 
ulnar neuropathy 2 (0.2%) and chemical meningitis (culture negative/aseptic meningitis attributable to 
neurosurgery) (2, 0.2%). Chemical meningitis was a transient adverse event while the others lasted for more 
than 3 months 
 
3.4 Adverse events involving lesionectomies 
There were 118 (13%) lesionectomies performed in the whole series during this period which were 
complicated by the following neurological adverse events: quadrantanopia (8, 6.8%), hemianopia (2, 1.7%), 
hemiparesis/sensory loss (1, 0.8%), monoparesis/sensory loss (2, 1.7%), dysphasia (4, 3.4%), frontalis 
muscle weakness (1, 0.8%). The total neurological adverse event rate for lesionectomies was 15.3% 
(18/118).  
Surgery-related adverse events of lesionectomies included CSF-leak (1, 0.8%) superficial infection (3, 2.5%), 
infection requiring bone flap removal (4, 3.4%) and extra-surgical site infections (2, 1.7%).  
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3.5 Temporal analysis 
During the last 5 years (2010-14) of this cohort, relatively more people have had extra temporal surgery 
(27.6% of all procedures), compared with 14.7% in the first 5 years (1990-1994). This was not associated 
with an increase in expected persistent neurological adverse events (Table 4).  During the last 5 years, a 
higher proportion of individuals have undergone intracranial EEG monitoring (34.9%), compared with the 
1990s (10%).  
 
4. Discussion 
Direct comparisons of adverse event rates with other series are difficult as different definitions of adverse 
events have been used, with differences in the range of procedures, in the clinical characteristics of the 
cohorts, and in data collection methods.  
In a systematic review of 76 series with different methodologies, 5% major and 11% minor neurological 
adverse events were found (Hader et al., 2013). Major adverse events were defined in a similar way we used. 
Our cohort had a persistent unexpected neurological adverse event rate of 2.2% and transient unexpected 
rate of 1.9%, which were lower than the quoted rates. The review, however, also included children, who had 
higher adverse event rates (11.2% vs. 5.5%; including minor neurological adverse events) than adults, which 
may have contributed towards a rate higher than ours. The higher rate reported in the review may also have 
included both expected and unexpected adverse events (as no such categorization was made).  Different 
definitions for neurological adverse events in the paediatric age group may also contribute to the difference.     
A recent prospective Swedish study of 865 procedures reported a total major adverse event rate of 3% and 
minor adverse event rate of 7.5% (Bjellvi et al., 2015). Only unexpected post-operative neurological 
impairment was recorded, comparable with our unexpected neurological adverse events. The major 
neurological adverse event rate was 2.9% while the minor neurological adverse events rate was 3.6%, with 
slightly fewer adverse events seen in our cohort than in the Swedish cohort    
The most severe physical adverse events of epilepsy surgery are the neurological adverse events affecting 
vision, motor system (especially hand function) and speech that do not resolve and therefore have the 
potential to affect long-term quality-of-life (Hader et al., 2013). Dissatisfaction after surgery, even in those 
who are seizure free is mainly related to post-operative neurological deficits (Macrodimitris et al., 2011). 
Permanent neurological consequences of resective surgical procedures are often associated with the site of 
the procedure.  Our findings suggest that persistent unexpected neurological adverse events after surgery are 
low. The acceptance of an expected persistent neurological adverse event by an individual suggests that some 
are willing to accept certain neurological deficits to be seizure-free.   
The review found 1.5% major and 5.1% minor surgical adverse events (Hader et al., 2013). Our cohort had a 
total procedure related adverse event rate of 9.1%, higher than in the review. This rate is also higher than the 
Swedish study (5.2%) (Bjellvi et al., 2015). Late surgical adverse events, such as hydrocephalus developing 
several months after surgery, would not, however, have been included in the Swedish study as adverse events 
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were specifically addressed only during the post-operative in-hospital stay and at follow-up 3 months after 
surgery. Such late adverse events were reported in our cohort, which had continuing follow-up for up to 24 
years (median 9 years).  
Our infection rate (7.9%) was a major contributor to the total adverse events rate, with 2.6% requiring bone-
flap removal and 0.9% having intracranial infection. A higher rate of infection was associated with subdural 
EEG monitoring.  
A higher number of intracranial electrodes and longer duration of monitoring has been associated with 
increased frequency of adverse events (Hedegärd et al., 2014).  However, we did not find any significant 
difference between duration and severe infection in our cohort. In one review, infections were the most 
common type of adverse events in invasive EEG monitoring with a prevalence of 5.3% (2.3% neurological 
infections and 3.0% superficial infections) (Arya et al., 2013). Some series reported infection rates as high as 
15% (Blauwblomme et al., 2011; Simon et al., 2003). In one prospective study, the infection rate was higher if 
more than 100 electrode contacts (combined subdural grid and strip electrodes) were used, if more than 10 
electrode cables were present, or if electrodes remained implanted for more than 14 days (Wiggins et al., 
1999).   Widespread usage of SEEG rather than subdural grids occurred after August 2011 in our cohort and 
only one was complicated by severe infection.   
Several series have indicated age as a risk factor for adverse events in epilepsy surgery (Grivas et al., 2006; 
Rydenhag and Silander, 2001). In some studies, however, there was no difference in adverse events rates for 
individuals younger or older than 50 years (Patra et al., 2014; Murphy et al., 2014). The Swedish study 
showed a positive association with age and adverse events rate (Bjellvi et al., 2015). We found no association 
between age and occurrence of persistent unexpected neurological adverse events.   
We carried out a sub-analysis of somatic adverse events of both temporal and extra-temporal resections. The 
following discussion focuses mainly on adverse events of temporal lobe resections to facilitate comparison 
with similar large series. Our neurological adverse event rate was comparable to rates reported in temporal 
lobe resections series. A review (Georgiadis et al. 2013) quoted the occurrence of hemiparesis post-
operatively in adults of up to 5%, with a wide range of severity, duration, and rehabilitation rates. Dysphasia 
occurred in 1.7 - 7.7%, and this was permanent in 0.9%.  Trochlear nerve palsy has been reported to occur in 
2.6% - 19% following temporal lobe resections. In the vast majority of cases, post-operative diplopia 
spontaneously resolved with no sequelae. In contrast, post-operative visual field defects were permanent. 
Their incidence rates ranged from 1.8%-69%. In the vast majority of the reported series, these visual field 
defects were superior quadrantanopias. Hemianopia was reported in 1.8%-5.8%.  Palsy of the frontal branch 
of the facial nerve was seen between 1.7% and 2.6% of temporal lobe procedures.  
Post-operative infection rates of 1%-4.7% have been reported after temporal lobe resection (Georgiadis et al. 
2013). The incidence of meningitis was 1.8%-4.7%. The infection rate in our series of temporal lobe resection 
was 6.5%. The incidence of post-operative haematoma was 1.8% - 3.8% and DVT occurred in 1.8% of 
individuals (Georgiadis et al. 2013). Our rates were lower than these.     
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A recent meta-analysis (Tebo at al., 2014) of post-surgical adverse events between 1980 and 2012 suggested 
that the most frequent complications after temporal lobectomy were neurological complications (19.3%), 
which were persistent in 3.8%. The total neurological complication rate in our temporal lobe series (17.7%) 
was lower, although persistent adverse events were much higher (16.4%). This may have been due to 
differences in definitions whereby cerebral vascular events (which can cause persistent neurological deficit) 
were defined as separate from neurological deficits in the review.  
Superior quadrantanopia in temporal lobe resections is the commonest adverse event and was seen in 10.5% 
of temporal lobe procedures in our cohort. This adverse event results from injury to Meyer’s loop as it passes 
through the roof of the lateral ventricle (Vale et al., 2013). Minor, non-clinically significant injury to Meyer’s 
loop may occur during surgery, resulting in a field deficit only detectable by visual field perimetry, and not by 
the individual or by a confrontational visual field examination (Grivas et al., 2006). Different visual field 
examination methodologies may provide different detection rates (Manji and Plant, 2000; Nilsson et al., 
2004).  An incidence of field deficit of 47% when using the Esterman method, and 54% with Goldman 
perimeter has been reported (Chen et al., 2009).     
The use of preoperative diffusion imaging and tractography can help in outlining the optic radiation (Powell 
et al., 2005). Registration of the tractography data on the preoperative neuro-navigational planning may 
mitigate the risk to the optic radiation, without compromising seizure outcome (Winston et al., 2014). 
Post-operative hemiparesis after temporal lobe resection are due to vasospasm or cerebral oedema 
secondary to surgical manipulation (Heller et al. 2009; Schaller 20045), with persistent hemiparesis usually 
due to damage to vessels supplying the internal capsule (Shorvon and Moran, 2009). We found persistent 
hemi/monoparesis after 0.8% of temporal lobe resections.  
Permanent dysphasia may occur when a dominant anterior temporal lobe resection is extended too far 
posteriorly or when a lesionectomy is carried out in or under the posterior temporal neocortex (Roberti et al., 
2007). The anatomical location of language function in individuals with temporal lobe epilepsy can be 
extremely variable, and dysphasia may occur even if the resection avoids the conventional anatomical 
locations of eloquent language cortex. The risk can be reduced but not eliminated by preoperative language 
mapping. Unexpected persistent dysphasia was seen in 1.3% of temporal lobe procedures in our cohort.          
The frontal branch of the facial nerve superior to the zygoma courses within the superficial temporal fascia. 
This is therefore vulnerable during skin incision, especially in temporal lobe resections. This was damaged 
following 3.5% of temporal lobe resections. Surgical adverse events related to the skin incision or the 
craniotomy may be prevented by employing interfascial dissection to avoid injuries to the frontal branch of 
the facial nerve and thus accomplish a better post-operative cosmetic result (Georgiadis et al. 2013; Roberti 
et al., 2007).   
The meta-analysis (Tebo at al., 2014) found higher rates of neurological deficit in extra-temporal resections 
and also higher rates of infection/ meningitis compared to temporal resections (temporal vs extra temporal 
neurological deficits- 19.3% vs 23.8%, infection 1.4% vs 3.1%). This was similar to our findings. The 
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additional risk of intracranial electrode implantation may explain this difference as this was more likely with 
extra-temporal resections.  
Persistent headache was seen after 1.8% of total procedures in our cohort. Currently, in the International 
Classification of Headache Disorders for a headache to be classified as “headache attributed to craniotomy,” 
the craniotomy needs to have been performed for reasons other than for traumatic brain injury, and the 
headache needs to have started within 7 days after the surgery. If the pain lasts for less than 3 months, the 
headache is classified as acute; if not, as persistent (Rocha-Filho et al., 2015). 
The majority of individuals report headaches on the same side as, and at the site of, the surgery. The most 
frequent pattern is a “tension-type headache” pattern. Allodynia at the site of the surgical scar is reported by 
82% and is considered to be a problem by 19%.  “Tenderness” at the incision site can last for an average of 12 
months (Mosek et al., 1999). 
Retrospective studies have shown a range in the incidence of headache from 0% to 100 % (Rocha-Filho et al., 
2015). One study investigated 145 people who underwent anterior temporal lobe resections for intractable 
epilepsy over a 9-year period (Kaur et al., 2000). To eliminate confounding causes of headache, all individuals 
studied were seizure-free, none had progressive mass lesions or persisting vascular anomalies, and none had 
major complications of surgery. Six per cent complained of headaches that lasted for more than 2 months but 
less than 1 year, and 12% had on going headaches 1 year post-operatively. Of these, a quarter had medically 
uncontrolled headaches, whilst a third continued to require regular analgesia a year after surgery.  
Possible causes of post-craniotomy headache include meningeal inflammation (Jackson et al. 2000), nerve 
compression, nerve entrapment, muscular and meningeal fibrosis (Harner et al., 1995) neuromas or nerve 
entrapment in a scar (Ferreira et al., 2012). Most individuals with chronic pain can be successfully treated 
with a combination of pharmacological and non-pharmacological approaches (de Gray and Matta, 2005). 
 
5. Conclusion 
Epilepsy surgery carries well defined surgical and neurological risks. The risks of somatic adverse events, in 
addition to neuropsychiatric and neuropsychological complications, need to be made clear to individuals 
considering this treatment option, and balanced against the risks of morbidity and mortality from continued 
seizures, and the chances of seizure remission with surgery. There is scope to reduce the risks of 
complications and this requires on-going sustained efforts. 
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Table 1: Descriptive analysis of procedures with adverse events  
 Total (no,%) Number (%) of procedures with adverse events 
Total  *Neurological 
alone 
Surgical alone *Neurological+ 
surgical(combined) 
Operation type (anatomical)      
Temporal lobe 764 (100) 183 (24.0) 125 (16.4) 48 (6.3) 10 (1.3) 
Extratemporal 147 (100) 57 (38.8) 32 (21.8) 15 (10.2) 10 (6.8) 
 Frontal    91 (100)  33 (36.3)   17 (18.7)  8 (8.8)  8 (8.8) 
  Parietal    21 (100)  12 (57.1)   8 (38.1)  4 (19.0)  0 
  Occipital    10 (100)  4 (40.0)  4 (40.0)  0  0 
  Hemispherectomy    16 (100)  6 (37.5)   3 (18.8)  2 (12.5)  1 (6.2) 
 Multiple subpial transections    4 (100)  2 (50.0)  0  1 (25.0)  1 (25.0) 
 Corpus callosotomy    5 (100)  0  0  0  0 
 
Total procedures 911 (100) 240 (26.3) 157 (17.2) 63 (6.9) 20 (2.2) 
 
Procedure type 
     
Lesionectomy (Temporal and 
extratemporal) 
118 (100) 26 (22) 16 (13.6) 8 (6.8) 2 (1.7) 
Other  793 (100) 213(26.9) 141 (17.8) 54 (6.8) 18 (2.3) 
Note: There were a total of 311 adverse events recorded in 240 procedures 
*Total procedures with neurological adverse events = Neurological alone + Neurological and Surgical combined     
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Table 2: Neurological adverse events 
 
Neurological 
adverse events 
Total (n=911) Temporal lobe procedure (n=764) Extra Temporal lobe procedures (n=147) 
Numbers Persistent Transient 
Number
s 
Persistent Transient 
Number
s 
Persistent Transient 
 E U E U  E U E U  E U E U 
Procedures with 
adverse events* 
177 
(19.4) 
137 
(15.0) 
20 
(2.2) 
3 
(0.3) 
17 
(1.9) 
135 
(17.7) 
106 
(13.9) 
19 
(2.5) 
1 
(0.1) 
9 
(1.2) 
42 
(28.6) 
31 
(21.1) 
1 
(0.7) 
2  
(1.4) 
8 
(5.4) 
Quadrantanopia 
85 (9.3) 77 
(8.4) 
6 
(0.7) 
2 (0.2) 0  80 
(10.5) 
72 
(9.4) 
6 (0.8) 2 (0.3) 0  5 (3.4) 5 (3.4)  0 0 0 
Hemianopia 
13 (1.4) 10 
(1.1) 
2 
(0.2) 
1 (0.1) 0  3 (0.4) 1 (0.1) 2 (0.3) 0  0  10 (6.8) 9 (6.1) 1 (0.7) 0 0 
Hemiparesis/ 
Sensory loss 
27 (3.0) 5 
(0.5) 
9 
(1.0) 
6 (0.7) 7 (0.8) 10 (1.3) 1 (0.1) 6 (0.8) 0  3 (0.4) 17 
(11.6) 
4 (2.7) 6 (4.1) 3 
(2.0) 
4 
(2.7) 
Monoparesis/ 
Sensory loss 
9 (1.0) 6 
(0.7) 
0  1 (0.1) 2 (0.2) 1 (0.1) 0  0  0  1 (0.1) 8 (5.4) 6 (4.1) 1 (0.7) 0 1 
(0.7) 
Dysphasia 
36 (4.0) 6 
(0.7) 
10 
(1.1) 
17 (1.9) 3 (0.3) 25 (3.3) 3 (0.4) 10 
(1.3) 
11 
(1.4) 
1 (0.1) 11 (7.5) 3 (2.0) 6 (4.1) 0 2 
(1.4) 
Frontalis 
weakness 
28 (3.1) 19 
(2.1) 
2 
(0.2) 
6 (0.7) 1(0.1) 27 (3.5) 19 
(2.5) 
2 (0.3) 5(0.6) 1 (0.1) 1 (0.7) 0 1 (0.7) 0 0 
Oculomotor 
7 (0.8) 2 
(0.2) 
1 
(0.1) 
3 (0.3) 1 (0.1) 6 (0.8)  2 (0.3) 0  3 (0.4) 1 (0.1) 1 (0.7) 0 0 1 
(0.7) 
0 
*One procedure may give in to >1 adverse event 
Legend: E; expected U=unexpected 
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Table 3: Surgical adverse events  
Notes: *IC indicates “Intracranial Monitoring”, SD= Subdural grid, SEEG= Stereo EEG 
1. Procedures which underwent intracranial monitoring (IC) total =168 (temporal =96; extratemporal=72) and procedures which had not undergone IC =743 
(temporal =668; extratemporal=75) 
  Temporal lobe procedure Extra temporal lobe procedure 
Surgical adverse 
events 
Total  
(n=911) 
With IC* (n=96) Without IC*  With IC* (n=72) Without IC* 
SD alone Combination SEEG alone Total (n=668) 
SD 
alone 
Combination 
SEEG 
alone 
Total (n=75) 
CSF Leak (needing 
resuture) 
11 (1.2) 0 1 (1.0) 0 1 (1.0) 8 (1.2) 0 0 0 0 2 (2.7) 
DVT 1 (0.1) 0 0 0 0 0 0 0 0 0 1 (1.3) 
Infection-
Superficial 
surgical site 
35 (3.8) 1 (1.0) 2 (2.1) 1 (1.0) 4 (4.2) 26 (3.9) 0 2 (2.8) 0 2 (2.8) 3 (4.0) 
Infection-
intracranial 
8 (0.9) 0 1 (1.0) 0 1 (1.0) 5 (0.8) 0 0 0 0 2 (2.7) 
Infection-Bone 
flap removed 
24 (2.6) 0 3 (3.1) 1 (1.0) 4 (4.2) 6 (0.9 ) 3 (4.2) 7 (9.7) 0 10 (13.9) 4 (5.3) 
Infection – other 
sites 
5 (0.5) 0 0 0 0 (0 ) 4 (0.6) 0 0 0 0 1 (1.3) 
Haematoma 3 (0.3) 0 0 0 0 (0 ) 2 (0.3) 0 0 0 0 1 (1.3) 
Hydrocephalus 3 (0.3) 0 0 0 0 (0 ) 2 (0.3) 0 0 0 0 1 (1.3) 
Headache 16 (1.8) 0 1 (1.0) 0 1 (1.0) 14 (2.1) 0 1 (1.4) 0 1 (1.4) 0 
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Table 4 –Analysis of persistent neurological adverse events in 5 year epochs 
 
*IC – individuals who have undergone intra-cranial monitoring in 5-year epochs 
 
 
  
Years Total number of 
operations 
 
Temporal Extra –temporal 
 
*IC  Persistent neurological adverse events 
Unexpected Expected 
1990 – 1994  116  99 (85.3%) 17(14.7%)  9 (7.8%) 5 (4.3%) 20 (17.2%) 
1995 – 1999  222  195 (87.8%)  27 (12.2%) 25 (11.3%) 4 (1.8%) 18 (8.1%) 
2000 – 2004 176  150 (85.2%) 26 (14.8%) 28 (15.9%) 1 (0.6%) 12 (6.8%) 
2005 – 2009 205  181 (88.3%)  24 (11.7%) 39 (19%) 10 (4.9%) 28 (13.7%) 
2010 – 2014 192  139 (72.4%) 53 (27.6%)  67 (34.9%) 6 (3.1%) 29 (15.1%) 
Total  911  764 (83.9%)  147 (16.1%)  168 (18.4%) 26 (2.9%) 107 (11.7%) 
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Figure 1 – Categories of adverse events 
  
Adverse events 
Neurological Adverse events 
 Quadrantanopia 
 Hemianopia 
 Hemiparesis/sensory loss 
 Monoparesis/ sensory loss 
 Dysphasia 
 Oculomotor weakness  
 Frontalis weakness 
Surgical Adverse events 
 Infection needing antibiotics 
 Venous thrombosis (DVT)/ pulmonary 
embolism (PE) 
 Hydrocephalus,  
 Headache  
 CSF leakage needing re-suturing 
Persistent 
Lasting >3 months 
Transient 
Lasting ≤3 months 
Expected Unexpected Expected Unexpected 
Surgical site Infection 
  
 
Severe 
Intracerebral/epidura
l abscesses 
Meningitis 
Infection requiring 
bone flap removal 
Non severe 
Superficial infection 
Other sites of 
infection  
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Figure 2 - Flow chart depicting procedures with adverse events 
 
Total surgical procedures 
(n=911) 
Temporal surgical 
procedures (n=764) 
Extra-temporal surgical 
procedures (n=147) 
Procedures with Neurological 
Adverse event (n=135, 17.7%) 
Procedures with Neurological 
Adverse event (n=42, 28.6%) 
Procedures with Surgical Adverse 
event (n=25, 17%) 
Procedures with Surgical Adverse 
event (n=58, 7.6%) 
Persistent 
(n=32, 21.8%) 
Transient 
(n=10, 6.8%) 
Persistent 
(n=125, 16.4%) 
Transient 
(n=10, 1.3%) 
*E 
(n=106, 
13.9%) 
*U 
(n=19, 
2.5%) 
*E 
(n=1, 
0.1%) 
*U 
(n=9, 
1.2%) 
*E 
(n=31, 
21%) 
*U 
(n=1, 
0.7%) 
*E 
(n=2, 
1.4%) 
*U 
(n=8, 
5.4%) 
*E= expected 
*U=unexpected 
 
